国际肥胖与代谢病外科联合会（IFSO）关于肥胖管理药物在代谢性减重手术中的作用的国际共识立场声明：专家指南 - Suppr | 超能文献

相似文献

1

International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO).国际肥胖与代谢病外科联合会（IFSO）关于肥胖管理药物在代谢性减重手术中的作用的国际共识立场声明：专家指南

Br J Surg. 2024 Nov 27;111(12). doi: 10.1093/bjs/znae283.

2

IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures.国际肥胖与代谢外科学会关于减重与代谢手术前后行上消化道内镜检查作用的立场声明

Obes Surg. 2020 Aug;30(8):3135-3153. doi: 10.1007/s11695-020-04720-z.

3

IFSO Update Position Statement on One Anastomosis Gastric Bypass (OAGB).国际肥胖与代谢外科学会关于单吻合口胃旁路术（OAGB）的更新立场声明。

Obes Surg. 2021 Jul;31(7):3251-3278. doi: 10.1007/s11695-021-05413-x. Epub 2021 May 3.

4

Barrett's Oesophagus and Bariatric/Metabolic Surgery-IFSO 2020 Position Statement.巴雷特食管和减重代谢手术-IFSO 2020 立场声明。

Obes Surg. 2021 Mar;31(3):915-934. doi: 10.1007/s11695-020-05143-6. Epub 2021 Jan 18.

5

IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management.国际肥胖与代谢病外科联盟（IFSO）肥胖症内镜治疗委员会关于内镜下袖状胃成形术治疗肥胖症的循证回顾与立场声明。

Obes Surg. 2024 Dec;34(12):4318-4348. doi: 10.1007/s11695-024-07510-z. Epub 2024 Nov 1.

6

The IFSO Website (www.ifso.com): the Online Gateway to Obesity and Metabolic Disorders for Bariatric Surgery Professionals and Patients: On behalf of the IFSO Communications Committee.国际肥胖与代谢病外科联盟网站（www.ifso.com）：肥胖症和代谢紊乱疾病的在线门户，面向减重手术专业人士和患者：代表国际肥胖与代谢病外科联盟通讯委员会。

Obes Surg. 2015 Nov;25(11):2176-9. doi: 10.1007/s11695-015-1843-z.

7

Reply to a Letter to the Editor: Bariatric Surgery in Class I Obesity. A Position Statement from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)--Obesity Surgery 2014;24:487-519.

Obes Surg. 2015 Oct;25(10):1942. doi: 10.1007/s11695-015-1796-2.

8

A Global Survey by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) on Perceptions of Bariatric Medical Tourism (BMT) by Health Professionals: Guidelines from IFSO for BMT.国际肥胖与代谢外科联合会（IFSO）关于医疗旅游对肥胖和代谢紊乱手术（BMT）的看法的全球调查：IFSO 关于 BMT 的指南。

Obes Surg. 2021 Apr;31(4):1401-1410. doi: 10.1007/s11695-020-05185-w. Epub 2021 Jan 2.

9

2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery.2022年美国代谢与减重外科学会（ASMBS）和国际肥胖与代谢病外科联盟（IFSO）：代谢与减重手术的适应证

Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013. Epub 2022 Oct 21.

10

IFSO (International Federation for Surgery of Obesity and Metabolic Disorders) Consensus Conference Statement on One-Anastomosis Gastric Bypass (OAGB-MGB): Results of a Modified Delphi Study.国际肥胖与代谢外科联合会（IFSO）关于单吻合口胃旁路术（OAGB-MGB）的共识会议声明：一项改良 Delphi 研究的结果。

Obes Surg. 2020 May;30(5):1625-1634. doi: 10.1007/s11695-020-04519-y.

引用本文的文献

1

Pharmacotherapy and metabolic/bariatric surgery: either or both?药物治疗与代谢/减重手术：选其一还是两者皆选？

Int J Obes (Lond). 2025 Aug 30. doi: 10.1038/s41366-025-01897-0.

2

The effect of weight change on death and cardiovascular events after Roux-en-Y gastric bypass.Roux-en-Y胃旁路术后体重变化对死亡和心血管事件的影响。

Br J Surg. 2025 Aug 1;112(8). doi: 10.1093/bjs/znaf170.

3

Integrative Strategies in Primary Care: Addressing Recurrent Weight Gain Post-Metabolic and Bariatric Surgery.初级保健中的综合策略：应对代谢和减肥手术后体重反复增加的问题